Fast Five Quiz: Management of Anaplastic Thyroid Carcinoma

Lori J. Wirth, MD


June 21, 2023

Anaplastic thyroid carcinoma (ATC) is a rare but highly lethal type of thyroid cancer with one of the worst survival rates of all malignancies, a median of only about 5 months after diagnosis. It is encouraging that advances in therapy, including the introduction of molecular-based personalized therapies and multimodal strategies, appear to be associated with significant increases in survival. However, ATC's low responsiveness to many treatments leaves a long way to go to improve outcomes for more patients with this aggressive malignancy.

How much do you know about the management of ATC? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.